PROSTOX, a signature of late GU toxicity after SBRT radiotherapy in MIRAGE, a prospective trial.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.12039
Abstract: 12039 Background: PROSTOX is a germline genetic signature previously found to predict late Grade > 2 genito-urinary (GU) toxicity after stereotactic body radiotherapy (SBRT). MIRAGE is a clinical trial evaluating toxicity in patients treated with… read more here.
Keywords: prostox; mirage; trial; signature ... See more keywords